Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 8, 2012 - Issue 4
Submit an article Journal homepage
1,284
Views
13
CrossRef citations to date
0
Altmetric
Special Focus Review

Sipuleucel-T for the treatment of metastatic prostate cancer

Promise and challenges

Channing J. Paller Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Baltimore, MD USA
&
Emmanuel S. Antonarakis Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Baltimore, MD USACorrespondence[email protected]
Pages 509-519 | Published online: 01 Apr 2012

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Sidhant Jain & Sahil Kumar. (2020) Cancer immunotherapy: dawn of the death of cancer?. International Reviews of Immunology 39:5, pages 205-222.
Read now

Articles from other publishers (12)

Ramachandra Bondigalla, Gangu Naidu Challa, Srinivasa Rao Yarraguntla, Raju Bandu & Subba Reddy Alla. (2023) Characteristics, properties, and analytical and bio‐analytical methods of enzalutamide: A review. SEPARATION SCIENCE PLUS 6:4.
Crossref
John W. Hickey, Alyssa K. Kosmides & Jonathan P. Schneck. 2018. Biology of T Cells - Part A. Biology of T Cells - Part A 277 362 .
Channing J. Paller, Alexander P. Cole, Alan W. Partin, Michael A. Carducci & Norma F. Kanarek. (2017) Risk factors for metastatic prostate cancer: A sentinel event case series. The Prostate 77:13, pages 1366-1372.
Crossref
Joaquim Bellmunt & Irene Moreno. 2017. Management of Prostate Cancer. Management of Prostate Cancer 357 377 .
Renliang Yi, Baoxin Chen, Peng Duan, Chanjiao Zheng, Huanyu Shen, Qun Liu, Chen Yuan, Weilin Ou & Zhiheng Zhou. (2016) Sipuleucel-T and Androgen Receptor-Directed Therapy for Castration-Resistant Prostate Cancer: A Meta-Analysis. Journal of Immunology Research 2016, pages 1-10.
Crossref
Szymon Jarosławski & Mondher Toumi. (2015) Sipuleucel-T (Provenge®)—Autopsy of an Innovative Paradigm Change in Cancer Treatment: Why a Single-Product Biotech Company Failed to Capitalize on its Breakthrough Invention. BioDrugs 29:5, pages 301-307.
Crossref
Ida Silvestri, Susanna Cattarino, Anna Maria Aglianò, Giulia Collalti & Alessandro Sciarra. (2015) Beyond the Immune Suppression: The Immunotherapy in Prostate Cancer. BioMed Research International 2015, pages 1-9.
Crossref
Rajni Kannan, Kathleen Madden & Stephanie Andrews. (2014) Primer on Immuno-Oncology and Immune Response. Clinical Journal of Oncology Nursing 18:3, pages 311-317.
Crossref
Brian Wan-Chi Tse, Lidija Jovanovic, Colleen Coyne Nelson, Paul de Souza, Carl Andrew Power & Pamela Joan Russell. (2014) From Bench to Bedside: Immunotherapy for Prostate Cancer. BioMed Research International 2014, pages 1-11.
Crossref
Claudia Marcela Diaz, Alberto Chiappori, Luigi Aurisicchio, Ansuman Bagchi, Jason Clark, Sheri Dubey, Arthur Fridman, Jesus C Fabregas, John Marshall, Elisa Scarselli, Nicola La Monica, Gennaro Ciliberto & Alberto J Montero. (2013) Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors. Journal of Translational Medicine 11:1.
Crossref
Sakthivel Muniyan, Nagendra Chaturvedi, Jennifer Dwyer, Chad LaGrange, William Chaney & Ming-Fong Lin. (2013) Human Prostatic Acid Phosphatase: Structure, Function and Regulation. International Journal of Molecular Sciences 14:5, pages 10438-10464.
Crossref
Sosipatros A. BoikosEmmanuel S. Antonarakis. (2012) Immunotherapy for Prostate Cancer Enters Its Golden Age. Clinical Medicine Insights: Oncology 6, pages CMO.S7475.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.